Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cleinman Performance Partners is a North American healthcare business consultancy focused on independent optometry practices rather than a drug-development biotech or pharmaceutical company. The firm provides strategic consulting, peer-network programs, HR and staff development services, benchmarking, and practice transition advisory services for eye care practice owners. Founded in 1989 in Oneonta, New York, Cleinman has positioned itself as a long-standing advisor to larger private optometry practices seeking revenue growth, operational improvement, and succession planning. Effective January 1, 2025, the company was acquired by POD Marketing, although it continues to operate under the Cleinman brand. Its business is healthcare-adjacent and service-based, with no disclosed therapeutic pipeline, drug assets, or clinical-stage development programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cleinman Performance Partners.